simfer < similar < similarities

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f

List of bibliographic references

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]

Ident.	Authors (with country if any)	Title
000232 (2020)	Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou [Taïwan] ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan]	The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
000250 (2020)	Yan-Chao Li [République populaire de Chine] ; Wan-Zhu Bai [République populaire de Chine] ; Tsutomu Hashikawa [Japon]	The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
000277 (2020)	Qiang Ding [République populaire de Chine] ; Panpan Lu [République populaire de Chine] ; Yuhui Fan [République populaire de Chine] ; Yujia Xia [République populaire de Chine] ; Mei Liu [Allemagne]	The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China.
000315 (2020)	Lan Zhu [République populaire de Chine] ; Xizhen Xu [République populaire de Chine] ; Ke Ma [République populaire de Chine] ; Junling Yang [République populaire de Chine] ; Hanxiong Guan [République populaire de Chine] ; Song Chen [République populaire de Chine] ; Zhishui Chen [République populaire de Chine] ; Gang Chen [République populaire de Chine]	Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.
000317 (2020)	Swatantra Kumar [Inde] ; Vimal K. Maurya [Inde] ; Anil K. Prasad [Inde] ; Madan L B. Bhatt [Inde] ; Shailendra K. Saxena [Inde]	Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
000336 (2020)	Rossella Porcheddu ; Caterina Serra [Italie] ; David Kelvin [République populaire de Chine] ; Nikki Kelvin [Canada] ; Salvatore Rubino [Italie]	Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.
000406 (2020)	Carlo Basile [Italie] ; Christian Combe [France] ; Francesco Pizzarelli [Italie] ; Adrian Covic [Roumanie] ; Andrew Davenport [Royaume-Uni] ; Mehmet Kanbay [Turquie] ; Dimitrios Kirmizis [Royaume-Uni] ; Daniel Schneditz [Autriche] ; Frank Van Der Sande [Pays-Bas] ; Sandip Mitra [Royaume-Uni]	Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres.
000409 (2020)	Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Rachel Graham [États-Unis] ; Ralph S. Baric [États-Unis] ; Fang Li [États-Unis]	Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
000414 (2020)	Pete Kinross [Suède] ; Carl Suetens [Suède] ; Joana Gomes Dias [Suède] ; Leonidas Alexakis [Suède] ; Ariana Wijermans [Suède] ; Edoardo Colzani [Suède] ; Dominique L. Monnet [Suède] ; European Centre For Disease Prevention And Control Ecdc Public Health Emergency Team	Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020.
000443 (2020)	Pengcheng Zhou [République populaire de Chine] ; Zebing Huang [République populaire de Chine] ; Yinzong Xiao [République populaire de Chine] ; Xun Huang [République populaire de Chine] ; Xue-Gong Fan [République populaire de Chine]	Protecting Chinese Healthcare Workers While Combating the 2019 Novel Coronavirus.
000469 (2020)	Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong]	Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates
000486 (2020)	David A. Schwartz [États-Unis] ; Ashley L. Graham	Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
000503 (2020)	Kollengode Ramanathan [Australie] ; David Antognini [Australie] ; Alain Combes [France] ; Matthew Paden [États-Unis] ; Bishoy Zakhary [États-Unis] ; Mark Ogino [États-Unis] ; Graeme Maclaren [Australie] ; Daniel Brodie [États-Unis] ; Kiran Shekar [Australie]	Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.
000506 (2020)	Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]	Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000511 (2020)	Harrison X. Bai ; Ben Hsieh ; Zeng Xiong ; Kasey Halsey ; Ji Whae Choi ; Thi My Linh Tran ; Ian Pan ; Lin-Bo Shi ; Dong-Cui Wang ; Ji Mei ; Xiao-Long Jiang ; Qiu-Hua Zeng ; Thomas K. Egglin ; Ping-Feng Hu ; Saurabh Agarwal ; Fangfang Xie ; Sha Li ; Terrance Healey ; Michael K. Atalay ; Wei-Hua Liao	Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT.
000635 (2020)	Jason A. Tetro [Canada]	Is COVID-19 receiving ADE from other coronaviruses?
000644 (2020)	Muh-Yong Yen [Taïwan] ; Jonathan Schwartz [États-Unis] ; Shey-Ying Chen [Taïwan] ; Chwan-Chuen King [Taïwan] ; Guang-Yang Yang [Taïwan] ; Po-Ren Hsueh [Taïwan]	Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts.
000670 (2020)	Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande]	Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
000675 (2020)	Xi Xu ; Chengcheng Yu ; Jing Qu ; Lieguang Zhang ; Songfeng Jiang ; Deyang Huang ; Bihua Chen ; Zhiping Zhang ; Wanhua Guan ; Zhoukun Ling ; Rui Jiang ; Tianli Hu ; Yan Ding ; Lin Lin ; Qingxin Gan ; Liangping Luo ; Xiaoping Tang ; Jinxin Liu	Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2
000683 (2020)	Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine]	Hypothesis for potential pathogenesis of SARS-CoV-2 infection--a review of immune changes in patients with viral pneumonia.
000706 (2020)	Shweta Saraswat ; Meenakshi Chaudhary ; Deepak Sehgal	Hepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by in silico Modeling and Cell-Free Inhibition Assays

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i -k "similar" 

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i  \
                -Sk "similar" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    an2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    similar
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021